Agronomics Ltd (ANIC) - Total Liabilities

Latest as of June 2025: GBX147.60K GBX ≈ $17.96 USD

Based on the latest financial reports, Agronomics Ltd (ANIC) has total liabilities worth GBX147.60K GBX (≈ $17.96 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Agronomics Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Agronomics Ltd's total liabilities have evolved over time, based on quarterly financial data. See Agronomics Ltd (ANIC) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Agronomics Ltd Competitors by Total Liabilities

The table below lists competitors of Agronomics Ltd ranked by their total liabilities.

Company Country Total Liabilities
Black Widow Resources Inc
V:BWR
Canada CA$1.40 Million
Cyber Security 1 AB
ST:CYB1
Sweden €23.14 Million
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
Germany €18.41 Million
Zephyr Energy PLC
LSE:ZPHR
UK GBX34.75 Million
Baiya International Group Inc. Ordinary Shares
NASDAQ:BIYA
USA $4.40 Million
NewGenIvf Group Limited Class A Ordinary Shares
NASDAQ:NIVF
USA $6.82 Million
ENGAGE XR HLDGS EO-001
F:6VR
Germany €693.16K
Europejskie Centrum Odszkodowań SA
WAR:EUC
Poland zł94.12 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Agronomics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Agronomics Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 129.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.00 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.00 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Agronomics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Agronomics Ltd (2012–2025)

The table below shows the annual total liabilities of Agronomics Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-06-30 GBX147.60K
≈ $17.96
-11.17%
2024-06-30 GBX166.17K
≈ $20.22
-91.46%
2023-06-30 GBX1.95 Million
≈ $236.78
-21.70%
2022-06-30 GBX2.49 Million
≈ $302.39
+53.13%
2021-06-30 GBX1.62 Million
≈ $197.48
+1138.17%
2020-06-30 GBX131.08K
≈ $15.95
+100.86%
2019-06-30 GBX65.26K
≈ $7.94
+174.67%
2018-06-30 GBX23.76K
≈ $2.89
-20.92%
2017-06-30 GBX30.04K
≈ $3.66
-44.57%
2016-06-30 GBX54.20K
≈ $6.59
+71.51%
2015-06-30 GBX31.60K
≈ $3.84
-92.12%
2014-06-30 GBX400.98K
≈ $48.79
+1137.60%
2013-06-30 GBX32.40K
≈ $3.94
+1.57%
2012-06-30 GBX31.90K
≈ $3.88
--

About Agronomics Ltd

LSE:ANIC UK Asset Management
Market Cap
$790.61K
GBX6.50 Billion GBX
Market Cap Rank
#30627 Global
#846 in UK
Share Price
GBX6.15
Change (1 day)
+2.33%
52-Week Range
GBX5.28 - GBX9.20
All Time High
GBX37.00
About

Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biophar… Read more